[02199907-CF] CAS 9002-04-4 | NZ Bovine Thrombin, Low Specific Activity | MP bio
... people are viewing this right now
02199907-CF | CAS 9002-04-4 | NZ Bovine Thrombin,Low Specific Activity | MPBIO
Key Features and Details
Manufactured in a state-of-the-art facility in New Zealand using a chromatographic extraction process, under Quality Systems that are ISO Certified
| SKU | 02199907-CF |
| Alternate Names | Factor IIa; Thrombin from bovine plasma |
| Application Notes | Thrombin is used throughout the diagnostics industry in a variety of coagulation assays, clotting factor tests and defibrination of blood or plasma for serum controls. Thrombin is also used for site specific cleavage of recombinant fusion proteins, and in biochemical and medical research applications. Bovine Thrombin, low specific activity, is manufactured from New Zealand-sourced bovine plasma using prothrombin activated with thromboplastin extracted from bovine lung tissue. Thrombin is lyophilized in glass vials under vacuum to optimize product performance. Low specific activity thrombin has 90 – 300 NIH units/mg and greater than 50% total protein. Thrombin has been used in a study to assess persistent hypocoagulability in patients with septic shock. |
| Base Catalog Number | 199907 |
| Biochemical Physiological Actions | Serine protease that selectively cleaves Arg-Gly bonds in fibrinogen to form fibrin and fibrinopeptides A and B. |
| CAS # | 9002-04-4 |
| EC Number | 232-648-7 |
| Extinction Coefficient | E<sub>280</sub><sup>1%</sup> = 18.3 (human); E<sub>280</sub><sup>1%</sup> = 19.5 (bovine) |
| Format | Lyophilized powder |
| Grade | Analytical Grade |
| Hazard Statements | H315-H319-H334-H335 |
| Host | Bovine |
| pH | 7.0 – 8.0 |
| Protein or Enzyme Type | Plasma & Blood Proteins |
| RTECS Number | XO8950000 |
| Safety Symbol | GHS07, GHS08 |
| Specific Activity | 90 – 300 u/mg protein |
| Unit Definition | Activity is expressed in NIH units obtained by direct comparison to a NIH Thrombin Reference Standard, Lot K. The NIH assay procedure uses 0.2 mL of diluted plasma (1:1 with saline) as a substrate and 0.1 mL of albumin solution based on a modification of the method of Biggs. Only clotting times in the range of 15–25 seconds are used for determining thrombin activity. Optimal clotting temperature is 37 °C. |
| Usage Statement | Unless specified otherwise, MP Biomedical’s products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department. |
